Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price traded up 2% during mid-day trading on Monday . The stock traded as high as $2.12 and last traded at $2.08. 5,987 shares changed hands during trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $2.04.
Ampliphi Biosciences Stock Down 2.9 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Further Reading
- Five stocks we like better than Ampliphi Biosciences
- What is the Nasdaq? Complete Overview with History
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Calculate Inflation Rate
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
